Matching slides 25,056
Current window 10,861-10,890
Pages 836
Rows per page 30
Beat: Complicationclear collectionreset all

Beat

10,861-10,890 of 25,056

filter-aware
01
Slide 1
Company sponsored report.Focus Universal Inc. (FCUV) · Steve Silver
Research note Short seller Beat · Problem1 hit
03
Includes a highlighted quote from a peer-reviewed article regarding the system's inability to replace standard of care.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)1 hit
04
The slide presents qualitative evidence from industry representatives to frame AXDX's competitive position as limited by its narrow focus on blood stream infections and reliance on surrogate measurements.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)1 hit
05
The slide uses external citations (FDA approval, peer-reviewed article, ECCMID poster) to build a negative case against the subject technology.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
06
The slide uses a Q&A format to highlight technical and operational weaknesses in the AXDX Pheno system.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
07
The slide uses a combination of technical critique and competitive intelligence (QuantaMatrix interview) to undermine the value proposition of the Pheno system.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
08
The slide presents qualitative evidence from industry interviews and literature to argue against the economic viability of the Pheno system.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
09
The slide uses a Q&A format to present anecdotal evidence from industry reps and a physician to challenge the market value of rapid diagnostic systems.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
03
Image file not found at /tmp/legacy-images/c376647f4b11/slides/003.jpg; unable to inspect contents.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem & Complication1 hit
04
Image file not found at /tmp/legacy-images/c376647f4b11/slides/004.jpg; unable to inspect contents.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem & Complication1 hit
05
Image file not found at /tmp/legacy-images/c376647f4b11/slides/005.jpg; unable to inspect contents.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem & Complication1 hit
06
Image file not found at /tmp/legacy-images/c376647f4b11/slides/006.jpg; unable to inspect contents.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem & Complication1 hit
07
Image file not found at /tmp/legacy-images/c376647f4b11/slides/007.jpg; unable to inspect contents.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem & Complication1 hit
01
Slide 1
The slide uses a 'short thesis' narrative structure, highlighting a discovery of obscure rate filings to estimate losses.Mercury General Corporation (MCY) · Wolfpack Research
Research note Short seller Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
02
This is a research note page detailing specific claims regarding MCY's insurance exposure and regulatory filings.Mercury General Corporation (MCY) · Wolfpack Research
Research note Short seller Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
01
Slide 1
This is a classic short-seller research note (Wolfpack Research). It uses aggressive, accusatory language to frame the company as a fraud.Datavault AI Inc. (DVLT) · Wolfpack Research
Research note Short seller Beat · The CallLoop · Cost Of Inaction1 hit
02
This is a research note page detailing investigative findings on corporate governance and financial irregularities.Datavault AI Inc. (DVLT) · Wolfpack Research
Research note Short seller Beat · The CallLoop · The Reveal1 hit
02
Includes a qualitative discussion on M&A potential for ATOM.Atomera Inc. (ATOM) · Richard Shannon
Research note Short seller Beat · InterestLoop · Cost Of Inaction1 hit
01
Slide 1
This is a short-seller research report cover/summary page.Accor SA (AC) · Grizzly Research
Research note Short seller Beat · Problem & Complication1 hit
02
This is a highly controversial research note from a short-seller firm.Accor SA (AC) · Grizzly Research
Research note Short seller Beat · Problem & Complication1 hit
03
This is a short-seller research report page. It uses a 'villain' narrative structure to frame the company's ESG claims as hypocritical.Accor SA (AC) · Grizzly Research
Research note Short seller Beat · Problem & Complication1 hit
05
The slide uses a network diagram and an organizational chart to illustrate the connection between HelloFresh SE, DSR Ventures, and various real estate SPVs.HelloFresh SE (HFG) · Grizzly Research
Research note Short seller Beat · Complication1 hit
06
Includes a screenshot of a German Handelsbilanz (balance sheet) for DSR Ventures GmbH.HelloFresh SE (HFG) · Grizzly Research
Research note Short seller Beat · Complication1 hit
07
The slide uses a table to highlight the pattern of buy-then-pledge transactions by the CEO's entity, DSR Ventures.HelloFresh SE (HFG) · Grizzly Research
Research note Short seller Beat · Complication1 hit
08
Includes two data tables: one on share buyback history and one on insider option transactions.HelloFresh SE (HFG) · Grizzly Research
Research note Short seller Beat · Complication1 hit
09
Includes a screenshot of the HelloFresh IR website as evidence of the 'malfunction'.HelloFresh SE (HFG) · Grizzly Research
Research note Short seller Beat · Complication1 hit
03
The slide uses a narrative structure to build a case for a short position, citing specific financial and regulatory risks.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Problem1 hit
04
This is a research note page from Grizzly Reports detailing short-thesis arguments against NBEV.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Problem1 hit
05
The slide uses a 'Grizzly Reports' branding, indicating a short-seller research note style.New Age Beverage Corp. (NBEV) · Grizzly Reports
Research note Short seller Beat · Problem1 hit
01
Slide 1
Includes stock performance charts and a table comparing WUBA to FXI.58.com Inc. (WUBA) · Grizzly Research
Research note Short seller Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit